Alzheimer's Association Funding Program for Global Real-Word Data Programs (ALZ-RWD)

About this funding opportunity

Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ-RWD)

Share or print this page

Share to FacebookShare on XShare on BlueskyPrintBookmark Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ-RWD) Program objective

The collection of Real-World Data (RWD) is integral to the discovery, evaluation and evolution of novel avenues for the diagnosis, prevention, treatment and care of Alzheimer’s and other dementia. Furthermore, RWD can play a key role in the identification and understanding of health disparities, and the subsequent development and implementation of initiatives to advance health equity.

RWD platforms house data on patient health status and health care collected within real-world settings. To support the advancement of and opportunities for RWD platforms, the Alzheimer’s Association is launching a peer-reviewed funding program to augment and accelerate global initiatives aimed at developing, expanding and aligning RWD platforms’ infrastructure, data and impact.

This grant is open to international (non-U.S.) applications. Grant RFA

View program objectives, eligibility, submission process and more.

Download the RFA Pre-submission Inquiry Survey

Pre-submission inquiries are welcome at any time via the Pre-submission Inquiry Survey. Surveys will be reviewed by the Alzheimer’s Association. Those who meet the program objectives will be invited to submit full applications.

Start the Survey Program overview Funding and award period Eligibility Overview of submission criteria Budget Deadlines and award timeline Ethical and regulatory approvals Additional information Program overview

In late 2021, the Alzheimer’s Association launched the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) to connect clinical data from Alzheimer’s patients to a network of medical professionals and researchers to encourage robust information sharing and education, and to drive innovation in the ways we care for and treat Alzheimer’s disease and other dementia. To build on the global momentum in this field, the ALZ-RWD funding program aims to advance RWD by providing funds to develop, expand, and align RWD platforms’ infrastructure, data and impact globally.

Potential projects will differ depending upon the specific aims and stage of development of the individual RWD platform. Eligible projects should relate to the following areas of focus, but other projects will be considered: Platform development (e.g., feasibility studies) Platform expansion (e.g., the addition of modules to existing platforms in order to collect RWD on newly-approved treatments) Platform utilization (e.g., site start-up payments to incentivize platform utilization, or the production of educational materials) Data collection (e.g., the addition of remote data collection or biomarker assessments, salaries for technical staff) Data integration and linking (e.g., with electronic health records) Data analysis and publication (e.g., research studies)

For all applications, priority will be given to proposals that enhance harmonization and collaboration across global platforms and have the potential to advance health equity (e.g., support ensures that a platform’s population is representative of a defined community). Funding and award period

The Alzheimer’s Association has allocated up to USD $5,000,000 to fund the ALZ-RWD Program over the next three years, and will accept submissions on a rolling basis.

As the scope and duration of funding will differ with each individual application, it is anticipated that funding will range from USD$100,000 up to a maximum grant amount of USD$1,000,000. Project duration is 12-24 months. Each RWD platform is limited to one unique award through this program’s first iteration; with potential for follow-on funding.

Awarded projects will be evaluated on progress toward specific milestones; continued disbursement of funds is dependent on demonstrated progress toward key…

Topic areas: Life Sciences and Health.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are accepted on a rolling basis; there is no single fixed deadline.

Who can apply

This opportunity is open to the following applicant types:

• Not specified by the program.

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

Alzheimer's Association Funding Program for Global Real-Word Data Programs (ALZ-RWD) is administered by Alzheimer's Association (AA), listed via Alzheimer's Association.